Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04253756 · ClinicalTrials.gov registry record · NA
A Randomized Trial Examining Plasma Exchange Using the Becton Dickinson (BD) Catheter In an Outpatient Apheresis Unit
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT04253756 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 26 participants.
The verdict
NCT04253756, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This is a randomized pilot study of therapeutic apheresis procedures (TAP) using the current standard of care catheter (SOC) vs the BD Nexiva Diffusics Catheter. It is a single blinded, randomized study. Data will be used to refine and power a full randomized control trial. For this study, a sample of 33 encounters in each group (total of 66 encounters). The specific aim is to test the hypothesis that the 20-gauge BD Nexiva Diffusics Catheter provides the same efficacy and lower pain level with no increase in adverse events for patients undergoing apheresis treatments.
Interventions
- DEVICE 20-gauge BD Nexiva Diffusics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-03-31 |
| Est. Completion | 2021-05-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04253756
The ClinicalTrials.gov registry entry for NCT04253756 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 20-gauge BD Nexiva Diffusics is the first listed.
NCT04253756 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04253756 about?
NCT04253756 is a clinical study titled "A Randomized Trial Examining Plasma Exchange Using the Becton Dickinson (BD) Catheter In an Outpatient Apheresis Unit". This is a randomized pilot study of therapeutic apheresis procedures (TAP) using the current standard of care catheter (SOC) vs the BD Nexiva Diffusics Catheter. It is a single blinded, randomized study. Data will be used to refine and power a full randomized control trial. For this study, a sample ...
What is the current status of trial NCT04253756?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2020-03-31. Estimated completion is 2021-05-24.
What interventions are being tested in trial NCT04253756?
The interventions under investigation include: 20-gauge BD Nexiva Diffusics (DEVICE).
Who is sponsoring clinical trial NCT04253756?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.